Yavuz, D. Et Al. 2023. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEW ENGLAND JOURNAL OF MEDICINE , vol.389, no.24 , 2221-2232.

Yavuz, D., Lincoff , A. M., Tugce K Oral 1, Marie M Michelsen 1, Jorge Plutzky 1, Christoffer W Tornøe 1, Donna H Ryan 1;, K. B. ,. H. M. C. J. D. ,. S. S. E. ,. S. E. S. H. ,. G. K. H. ,. S. E. K. ,. R. F. K. ,. I. L. ,., & Trial Investigators, S., (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEW ENGLAND JOURNAL OF MEDICINE , vol.389, no.24 , 2221-2232.

Yavuz, DİLEK Et Al. "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes," NEW ENGLAND JOURNAL OF MEDICINE , vol.389, no.24 , 2221-2232, 2023

Yavuz, DİLEK Et Al. "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes." NEW ENGLAND JOURNAL OF MEDICINE , vol.389, no.24 , pp.2221-2232, 2023

Yavuz, D. Et Al. (2023) . "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes." NEW ENGLAND JOURNAL OF MEDICINE , vol.389, no.24 , pp.2221-2232.

@article{article, author={DİLEK YAVUZ Et Al. }, title={Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2023, pages={2221-2232} }